Clinical Trials

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT07343596 2026-04-22

Study to Identify Biomarkers of Oral Cavity Cancer Response to Neoadjuvant Immunotherapy Prior to Definitive Surgery

20 enrolled

Head & Neck

Mouth Neoplasms

NCT05047094 2026-04-06

Alpha Radiation Emitters Device (DaRT) in Combination With Check Point Inhibitor for the Treatment of Recurrent Unresectable or mHNSCC

Phase NA Active not recruiting

48 enrolled

DermatologicHead & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Squamous Cell, Recurrence, Skin Neoplasms

NCT02658279 2026-03-03

Pembrolizumab (MK-3475) in Patients With Recurrent Malignant Glioma With a Hypermutator Phenotype

27 enrolled

CNS

Glioma

NCT07436390 2026-03-02

MAK

132 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT07422779 2026-02-20

MAK

Phase NA Not yet recruiting

100 enrolled

Dermatologic

Melanoma, Skin Neoplasms

NCT07067450 2025-07-16

Adjuvant Immunotherapy for Esophageal Squamous Cell Carcinoma

98 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma

NCT04924374 2024-09-26

Microbiota Transplant in Advanced Lung Cancer Treated With Immunotherapy

25 enrolled

Phase NA Not yet recruiting

Lung Neoplasms, Neoplasms

NCT06549855 2024-08-12

PD-1 Inhibitor Combined With Progesterone Treatment in FST for Patients With MMRd Endometrial Cancer

10 enrolled

Gynecologic

Turcot syndrome, Endometrial Neoplasms, Carcinoma, Endometrioid

NCT03769129 2024-06-25

Evaluating the Safety and Efficacy of Pembrolizumab Combined With MWA for Advanced NSCLC

100 enrolled

Carcinoma, Non-Small-Cell Lung

NCT05368207 2024-03-13

Pemb-HT

Phase NA Enrolling by invitation

1 enrolled

Gynecologic

Ovarian Neoplasms, Carcinoma, Small Cell

NCT05745233 2023-08-24

Intraperitoneal Immune Checkpoint Inhibitor for Malignant Ascites

30 enrolled

Malignant Ascites

NCT06000358 2023-08-21

LUCACRIMUNO

120 enrolled

Lung Neoplasms, Neoplasms

NCT04793815 2023-06-29

Lung Cancer Cryo-Activation as a Novel Approach to Augment Immunotherapy Efficacy (CRYOVATE)

15 enrolled

Non-small Cell Lung Cancer Metastatic

NCT04801966 2023-05-10

TAILOR

Phase NA Terminated

3 enrolled

Tumor-Agnostic

Neoplasms

NCT05821751 2023-04-20

PRINCESS

40 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Neoplasm Metastasis

NCT04453046 2022-12-20

Hemopurifier Plus Pembrolizumab in Head and Neck Cancer

Phase NA Terminated

2 enrolled

Head & Neck

Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms

NCT05352165 2022-04-28

The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuvant Chemotherapy in Advanced Rectal Cancer

192 enrolled

Neoadjuvant Therapy

NCT05339581 2022-04-27

iPLENTY-pvtt

78 enrolled

Gastrointestinal

Carcinoma, Hepatocellular, Liver Neoplasms

NCT05233358 2022-02-10

HAIC Combined With Second-line "Target Immunity" for HCC With TACE Standard Treatment Low Response or Failure

176 enrolled

Gastrointestinal

Carcinoma, Hepatocellular

NCT02489357 2021-11-12

Pembrolizumab and Cryosurgery in Treating Patients With Newly Diagnosed, Oligo-metastatic Prostate Cancer

12 enrolled 5 charts

Genitourinary

Prostatic Neoplasms

NCT04393883 2020-11-30

A Study With Pembrolizumab for Non-small Cell Lung Cancer (NSCLC)

216 enrolled